Osorio A - Search Results

1

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Ovarian Tumor Tissue Analysis (OTTA) Consortium; Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Tołoczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf A, Ryan A, Chudecka-Głaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubiński J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Ursula E, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, Anna A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus S… See abstract for full author list ➔ Ovarian Tumor Tissue Analysis (OTTA) Consortium, et al. Among authors: osorio a. JAMA Oncol. 2017 Dec 1;3(12):e173290. doi: 10.1001/jamaoncol.2017.3290. JAMA Oncol. 2017. PMID: 29049607 Free PMC article.

2

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T. de la Hoya M, et al. Among authors: osorio a. Int J Cancer. 2002 Feb 1;97(4):466-71. doi: 10.1002/ijc.1627. Int J Cancer. 2002. PMID: 11802208

3

Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.

Osorio A, de la Hoya M, Rodríguez-López R, Martínez-Ramírez A, Cazorla A, Granizo JJ, Esteller M, Rivas C, Caldés T, Benítez J. Osorio A, et al. Int J Cancer. 2002 May 10;99(2):305-9. doi: 10.1002/ijc.10337. Int J Cancer. 2002. PMID: 11979449

4

Clustering of cancer-related mutations in a subset of BRCA1 alleles: a study in the Spanish population.

de la Hoya M, Sulleiro S, Osorio A, Díez O, Baiget M, Benítez J, Díaz-Rubio E, Caldés T. de la Hoya M, et al. Among authors: osorio a. Int J Cancer. 2002 Aug 10;100(5):618-9. doi: 10.1002/ijc.10527. Int J Cancer. 2002. PMID: 12124814

5

A rapid and easy method for multiple endocrine neoplasia type 1 mutation detection using conformation-sensitive gel electrophoresis.

Arancha C, Ruíz-Llorente S, Cascón A, Osorio A, Martínez-Delgado B, Benítez J, Robledo M. Arancha C, et al. Among authors: osorio a. J Hum Genet. 2002;47(4):190-5. doi: 10.1007/s100380200022. J Hum Genet. 2002. PMID: 12166655

6

No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families.

Rodríguez-López R, Osorio A, Sánchez-Pulido L, De La Hoya M, Barroso A, Caldés T, Benítez J. Rodríguez-López R, et al. Among authors: osorio a. Int J Cancer. 2003 Jan 1;103(1):136-7. doi: 10.1002/ijc.10766. Int J Cancer. 2003. PMID: 12455067 No abstract available.

7

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J. Palacios J, et al. Among authors: osorio a. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14. Clin Cancer Res. 2003. PMID: 14506147

8

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population.

Osorio A, Rodríguez-López R, Díez O, de la Hoya M, Ignacio Martínez J, Vega A, Esteban-Cardeñosa E, Alonso C, Caldés T, Benítez J. Osorio A, et al. Int J Cancer. 2004 Jan 1;108(1):54-6. doi: 10.1002/ijc.11414. Int J Cancer. 2004. PMID: 14618615

9

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Palacios J, Honrado E, Osorio A, Diez O, Rivas C, Benítez J. Palacios J, et al. Among authors: osorio a. J Natl Cancer Inst. 2004 May 5;96(9):712-4; author reply 714. doi: 10.1093/jnci/djh115. J Natl Cancer Inst. 2004. PMID: 15126609 Free article. No abstract available.

10

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Dopazo J, Rivas C, Benítez J. Palacios J, et al. Among authors: osorio a. Breast Cancer Res Treat. 2005 Mar;90(1):5-14. doi: 10.1007/s10549-004-1536-0. Breast Cancer Res Treat. 2005. PMID: 15770521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters